Adjuvant Capital is a life sciences venture capital firm focused on public health.
New York // Zürich
Joined October 2018
- Tweets58
- Following43
- Followers487
- Likes51
Adjuvant Capital retweeted
Congrats to @adjcap portfolio company Antiva on successfully closing a "rare" Series E financing to advance their potentially game-changing vaginal tablet treatment for pre-cancerous lesions caused by HPV. 👏👏
Excited to work with @MPMCapital and new CEO Kristine Ball to advance and expand the potential impact of this promising women's health technology, with huge thanks to former CEO and new board chair Gail Maderis and her team for getting us to this point.
fiercebiotech.com/biotech/an…
Adjuvant Capital retweeted
Minister of Development Cooperation @carogennez visited the 🇧🇪 Belgian company #Univercells yesterday with 🇰🇪 President @WilliamsRuto & Minister-President of Wallonia @eliodirupo.
Read more below ⤵️
ALT After a successful long-term collaboration with Afrigen on vaccines - a highlight of the recent 🇧🇪 State Visit to South Africa - the Belgian biopharmaceutical company Univercells now announces a new biomanufacturing training hub in #Kenya with #Unizima.
Adjuvant Capital retweeted
"Our vaccine candidate appears able to block surrogate SARS-CoV-2 replication in the nose before it reaches the lower airways or lungs."
💪💪💪
COVI-VAC, our intranasal #vaccine candidate, shows promising Safety and Immunogenicity results following our Phase 1 Trial. Learn more about our progress on COVI-VAC and how it differentiated compared to other #COVID19 vaccines. #machinelearning #SynBio prnewswire.com/news-releases…
Adjuvant Capital retweeted
Great to see two @adjcap portfolio companies collaborating on such an important project.
📢 We are pleased to announce a new research collaboration with @Codagenix, Inc. on an undisclosed, high-priority human vaccine target with global public health demand. Read the press release univercells.com/newsroom/cod…
#vaccinedevelopment #biologicsforall #globalhealth
Adjuvant Capital retweeted
$2 billion now seems trivial compared to the *trillions* of dollars of economic damage and stimulus costs from #COVID2019. We need a massive global ⬆️ in R&D funding and innovative financing tools, such as prizes, vouchers, stockpiles, or market-entry awards.
“Ending this pandemic, saving lives and protecting societies around the world, depends on science” - @wellcometrust Director @JeremyFarrar
We've made an urgent call for $2 billion to support the development of a #COVID19 vaccine⤵️ @thetimes
thetimes.co.uk/article/vacci…
Adjuvant Capital retweeted
Honored to work alongside @grockman, @kpk7767, @kadjuvant, @credibleutility, @serenestazure and the rest of @adjcap to further the "double-bottom-line" mission: invest in the most promising public health technologies and ensure they are made accessible to those who need them most
We are thrilled to announce Adjuvant I, a $300 million vehicle focused on supporting life sciences technologies to address high burden diseases in the developing world. bloomberg.com/news/articles/…
Adjuvant Capital retweeted
“As a company focused on science-based innovation to address some of society's most challenging healthcare issues, we are pleased to invest in @adjcap as part of our holistic global health strategy.” -- Dr. Lutz Hegemann of @Novartis
fiercebiotech.com/biotech/ga…
Adjuvant Capital retweeted
Congrats to my colleagues @kpk7767, @credibleutility, @lilly_dsb, and Jenny Yip on one of our boldest bets to date: a technology with the potential to cure HIV and other terrible chronic infections. Very excited to begin this journey with @ExcisionBiotx!
globenewswire.com/news-relea…
Adjuvant Capital retweeted
A look at our growth from @fredmgrier in @SDbusiness. We launched our #COVID19 test + expanded our team, manufacturing capabilities to meet lab testing demand during the pandemic. Looking forward to our growth this year! (Sub req’d) #pcr #diagnostics
ow.ly/RFHS50DeHYs
Adjuvant Capital retweeted
Congrats to our friends at @InDevR_Inc and @biological_e on the development of yet another much-needed innovation in the vaccine characterization space!
💉🔬🙅♀️ measles-rubella 🙅♀️🔬💉
@edtenent
prnewswire.com/news-releases…
Adjuvant Capital retweeted
Simply awesome!
A new milestone - over 2 million COVID-19 PCR tests shipped! We reached our second million twice as fast as our first. Now on to helping 3 million people get tested! #COVID19 #SARSCoV2 #diagnostics #pcr
Adjuvant Capital retweeted
Congratulations to our friends at Univercells on yet another incredible year!
Like everyone on the planet, we are even more excited about what 2021 will bring...
🎉 @BiologicsforAll 🎉
lecho.be/entreprises/pharma-…
Adjuvant Capital retweeted
Thrilled to announce that we've raised $10m from @adjcap in an extension of our Series C round. It will support global expansion & continued dev of our HDPCR™ platform + an expanded #COVID19 assay & genetic, oncology assays. bit.ly/36dV1mW #pcr #datascience #diagnostics
Adjuvant Capital retweeted
"If we get a vaccine for the coronavirus, it will immediately make our world a safer, easier, more reassuring place once again. That’s what vaccines do." 🌏
✏️@PerriKlass in @nytimes ⤵️
nytimes.com/2020/03/16/well/…
Adjuvant Capital retweeted
Vaccines are a miracle. But how exactly do they work? I explain the science behind vaccines and why our foundation’s investment in them is one of the best we’ve ever made: gatesnot.es/2SwwcgU
Adjuvant Capital retweeted
Michael Chang of @adjcap remarks that the antibiotics space lacks a procurement agency like @GAVI, but could benefit from subscription-like mechanisms for access. #AMRIncentives
Adjuvant Capital retweeted
@DukeMargolis is investigating population-based payments that create strong incentives for the development, availability, and appropriate use of priority antibiotics, and better reflect the #publichealth value effective antibiotics provide #AMRIncentives healthpolicy.duke.edu/sites/…
Adjuvant Capital retweeted
"Software is eating the way we make vaccines"
🖥️🍽️💉
Kudos to @adjcap investees @Codagenix and @Themis_Bio for leveraging next-generation technologies to test new vaccination approaches.
endpts.com/gates-vets-at-adj…
